Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Gilsbach, JM; Reulen, HJ; Ljunggren, B; Brandt, L; von Holst, H; Mokry, M; von Essen, C; Conzen, MA.
Early aneurysm surgery and preventive therapy with intravenously administered nimodipine: a multicenter, double-blind, dose-comparison study.
Neurosurgery. 1990; 26(3): 458-464. Doi: 10.1227/00006123-199003000-00013
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Co-Autor*innen der Med Uni Graz
Mokry Michael
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
A European, multicenter, prospective, randomized, double-blind, dose-comparison study on preventive therapy with intravenously administered nimodipine was performed to evaluate the efficacy and tolerability of two different doses: 2 and 3 mg/h. Two hundred four patients fulfilled the criteria for enrollment in the study: surgery within 72 hours after the last subarachnoid hemorrhage, and age between 16 and 72 years. All patients who had Hunt and Hess grades of I to III were operated upon; patients who had poor Hunt and Hess grades (IV-V) were operated on according to the surgeon's choice. This treatment regimen was associated with a low incidence of delayed neurological dysfunction with no significant difference between the two dosage groups: three patients (1.5%) remained severely disabled and two (1%) moderately disabled due to vasospasm with or without additional complications. Among the patients with Hunt and Hess grades of IV or V, the long-term outcome was favorable (good-fair) for 40% and unfavorable for 60%. Among the patients with grades of I to III, the long-term outcome was favorable for 89% and unfavorable for 11%.
Find related publications in this database (using NLM MeSH Indexing)
Dose-Response Relationship, Drug -
Double-Blind Method -
Female -
Humans -
Injections, Intravenous -
Intracranial Aneurysm - drug therapy
Male - drug therapy
Middle Aged - drug therapy
Multicenter Studies - drug therapy
Nimodipine - administration and dosage

© Med Uni Graz Impressum